GlobalData on MSN

Imbria randomises first subject in Phase IIb trial of nHCM therapy

Imbria Pharmaceuticals has randomised the first participant in FORTITUDE HCM, a Phase IIb trial of ninerafaxstat in ...
Hastings Tribune

Hastings faith groups now covering six nights per week with shutdown suppers

Two additional Hastings faith groups have joined a newly launched interchurch effort to provide hot meals for those affected ...